Promus PREMIER™ H7493952824400Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3
All models of Promus PREMIER (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729844877), received between Nov 30, 2016 and Mar 1, 2019 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Bent” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Bent1
- Break1
- Device Damaged by Another Device1
- Device Dislodged or Dislocated1
- Entrapment of Device1
- Use of Device Problem1
Patient problems
- No Consequences Or Impact To Patient2
- Bradycardia1
- No Patient Involvement1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryMar 1, 2019Use of Device Problem; Use of Device Problem
IT WAS REPORTED THAT PATIENT EXPERIENCED BRADYCARDIA. THE TARGET LESION WAS LOCATED IN THE RIGHT CORONARY ARTERY. A 4.00MM X 24MM PROMUS PREMIER DRUG-ELUTING STENT WAS ADVANCED AND IMPLANTED IN THE LESION. HOWEVER, IT WAS NOTED THAT THE IMPLANTED STENT WAS EXPIRED. DURING THE PROCEDURE, THE PATIENT EXPERIENCED BRADYCARDIA. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. THE PATIENT'S STATUS WAS WELL AND WAS DISCHARGED.
Patient problems: Bradycardia
MAUDE report 8381322 ↗MalfunctionMar 7, 2017Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. A 4.00X24MM PROMUS PREMIER¿ STENT WAS ADVANCED TO TREAT THE LESION. HOWEVER, IT WAS NOTED THAT THE STENT GOT DISLODGED FROM THE BALLOON. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6385094 ↗MalfunctionDec 20, 2016Break; Entrapment of Device; Break; Entrapment of Device
IT WAS REPORTED THAT CATHETER ENTRAPMENT AND SHAFT BREAK OCCURRED. DURING PREPARATION, A 4.00X24MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED OVER 014 THRUWAY GUIDE WIRE TO TREAT THE LESION. HOWEVER, THE STENT DELIVERY SYSTEM (SDS) BECAME STUCK ON THE WIRE. WHEN THE PHYSICIAN ATTEMPTED TO REMOVE THE SDS FROM THE GUIDEWIRE, THE STENT CATHETER BROKE. THE GUIDEWIRE AND THE SDS WERE REMOVED TOGETHER. THE PROCEDURE WAS COMPLETED WITH ANOTHER THRUWAY GUIDEWIRE AND ANOTHER PROMUS PREMIER¿ STENT. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Patient Involvement
MAUDE report 6190923 ↗MalfunctionNov 30, 2016Bent; Device Damaged by Another Device; Bent; Device Damaged by Another Device
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN A CORONARY ARTERY. AFTER A 145 GUIDEZILLA¿ GUIDE EXTENSION CATHETER WAS ADVANCED, A 4.00X24MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION. HOWEVER, THE PHYSICIAN FELT THAT THE STENT WAS GETTING CAUGHT IN BETWEEN THE GUIDEZILLA¿ AND THE GUIDE CATHETER. THE DEVICE WAS THEN REMOVED AND THE STENT WAS FOUND DAMAGED. THE PROCEDURE WAS COMPLETED WITH ANOTHER WITH SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6136020 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page